2 Top Biotech Stocks to Buy Right Now
September has historically been one of the worst months for the stock market. But for investors focused on the long term, this only means that if history repeats itself, we will come across shares of excellent companies trading for a discount in the next few weeks.
If you aren't willing to wait that long, there are excellent stocks that have lagged well below the broader market in the past year and are definitely worth consideration right now. Two that come to mind are Vertex Pharmaceuticals (NASDAQ: VRTX) and Exelixis (NASDAQ: EXEL). Let's see why, despite recent struggles, both of these biotechs may deserve a place in your portfolio.
Source Fool.com